These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 4967662

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
    Urbaszek W, Kalkowski H, Günther K, Splith G, Trenckmann H.
    Z Gesamte Inn Med; 1969 Feb 15; 24(4):102-8. PubMed ID: 4978753
    [No Abstract] [Full Text] [Related]

  • 3. [The influence of orally applied iproveratril (Verapamil) on coronayy blood flow, oxygen consumption and carbon dioxide formation in the human heart].
    Rudolph W, Kriener J, Meister W.
    Arzneimittelforschung; 1971 Apr 15; 21(4):462-5. PubMed ID: 5108271
    [No Abstract] [Full Text] [Related]

  • 4. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
    Fleckenstein A, Kammermeier H, Döring HJ, Freund HJ.
    Z Kreislaufforsch; 1967 Aug 15; 56(8):839-58. PubMed ID: 5592708
    [No Abstract] [Full Text] [Related]

  • 5. [Oxygen uptake and carbon dioxide release by the human heart under the influence of iproveratril (Verapamil)].
    Rudolph W, Meister W, Kriener J.
    Arzneimittelforschung; 1971 Apr 15; 21(4):458-62. PubMed ID: 5108140
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The actions of verapamil on experimental arrhythmias.
    Rodrigues-Pereira E, Viana AP.
    Arzneimittelforschung; 1968 Feb 15; 18(2):175-9. PubMed ID: 5695375
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effects of coronary vaso dilators on myocardial survival time in the rat under anoxia conditions].
    Urbaszek W, Tronicke E, Modersohn D, Uhlich C, Günther K, Pankau H.
    Z Gesamte Inn Med; 1974 Jul 01; 29(13):521-7. PubMed ID: 4218417
    [No Abstract] [Full Text] [Related]

  • 11. The qualitative dynamics of angina pectoris and the effect of certain drugs as recorded with the high-frequency (acceleration) direct body ballistocardiograph.
    Winer NJ.
    Bibl Cardiol; 1973 Jul 01; 0(31):181-8. PubMed ID: 4213474
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
    Votcal BE, Lozinskij LG, Goldberg VA, Venediktova MG, Gribova OA.
    Arzneimittelforschung; 1970 Sep 01; 20():Suppl 9a:1281+. PubMed ID: 5312386
    [No Abstract] [Full Text] [Related]

  • 14. [Substrate metabolism of the human heart under the influence of iproveratril (Verapamil)].
    Rudolph W, Meister W, Kriener J.
    Arzneimittelforschung; 1971 Apr 01; 21(4):449-58. PubMed ID: 5108139
    [No Abstract] [Full Text] [Related]

  • 15. Effect of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates.
    Winbury MM, Howe BB, Hefner MA.
    J Pharmacol Exp Ther; 1969 Jul 01; 168(1):70-95. PubMed ID: 4978326
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of Verapamil on the metabolism of myocardium].
    Haas H, Gokel M.
    Arzneimittelforschung; 1970 May 01; 20(5):647-55. PubMed ID: 4393245
    [No Abstract] [Full Text] [Related]

  • 17. [The inherent contractility-reducing effect of various beta-adrenolytic agents on a heart-lung preparation in the dog].
    Schmidt HD, Schmier J.
    Z Kreislaufforsch; 1967 Nov 01; 56(11):1137-50. PubMed ID: 5595876
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative studies in the heart-lung-preparation of dog on the action spectrum of verapamil, quinidine and some alpha- and beta-sympatholytics as well as the effect of adrenaline].
    Haas H, Igarashi T.
    Arzneimittelforschung; 1968 Nov 01; 18(11):1373-80. PubMed ID: 5755900
    [No Abstract] [Full Text] [Related]

  • 19. On the cardiac adrenergic blocking action of iproveratril in normal and coronary-ligated dogs.
    Melville KI, Garvey HL, Shister HE.
    Rev Can Biol; 1968 Sep 01; 27(3):225-35. PubMed ID: 5702439
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.